FORMULATION DEVELOPMENT AND IN VITRO CHARACTERIZATION OF TERNARY HYDROTROPIC SOLID DISPERSIONS OF ACECLOFENAC
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i9.45158Keywords:
Carrier, Crospovidone, Hydrotrope, Skimmed milk, Solid dispersion, Solubility enhancement, Superdisintegrant, Ternary mixture, ureaAbstract
Objective: Among the various strategies employed to enhance solubility, dissolution, and bioavailability of poorly soluble drugs in vivo, formulation of solid dispersion (SD) using hydrophilic and/or water-soluble carriers with varying physicochemical characteristics seems to be a developable, economically viable and easy option. The goal of the present study was to explore the possibilities of skimmed milk (SKM)-urea (U)-crospovidone (CP) as a novel ternary mixture of carrier-hydrotrope-superdisintegrant in SD of poorly water-soluble aceclofenac (ACF).
Methods: Compatibility of ACF and ternary mixture of SKM-U-CP was confirmed by FTIR spectroscopic analysis. SDs of ACF-SKM, ACF-SKM-U and ternary hydrotropic SD, and ACF-SKM-U-CP were prepared in varying ratios of 1:1–1: 5 for ACF-SKM; 1:5:0.5, 1:5:0.75, and 1:5:1 for ACF-SKM-U and 1:5:0.75:0.25–1:5:0.75:1 for ACF-SKM-U-CP by solvent evaporation technique and were characterized by their solubility enhancement (compared to pure drug) at 25°C and drug dissolution profiles in double-distilled water and phosphate buffer (pH 6.8).
Results: Based on solubility enhancement data (82.10% and 44.06%) and maximum cumulative percentage drug release data (88.45% in 9 min and 76.18% in 60 s) in double-distilled water and phosphate buffer, respectively, ACF-SKM-U(1:5:0.75) was found to the best among ACF-SKM and ACF-SKM-U SDs which were used for studying the effect of adding CP as superdisintigrant. ACF: SKM: U: CP (1: 5: 0.75: 0.50) exhibited maximum solubility enhancement of 83.92% and 49.69% and cumulative percentage release of 98.55 % in 9 min and 85.67 % in 60 s in double-distilled water and buffer, respectively.
Conclusion: Therefore, the novel ternary mixture of SKM-U-CP has demonstrated marginal superiority over SKM as carrier for from hydrotropic SDs of ACF.
Downloads
References
SSavjani KT, Gajjar AK, Savjani JK. Drug solubility: Importance and enhancement techniques. ISRN Pharm 2012;2012:195727.
Narayan K. Technologies to improve the solubility, dissolution and bioavailability of poorly soluble drugs. J Anal Pharm Res 2018;7:44-50.
Tekade AR, Yadav JN. A review on solid dispersion and carriers used therein for solubility enhancement of poorly water soluble drugs. Adv Pharm Bull 2020;10:359-69. doi: 10.34172/apb.2020.044, PMID 32665894
Maheshwari RK, Indurkhya A. Novel application of mixed hydrotropic solubilisation technique in the formulation and evaluation of hydrotropic solid dispersion of aceclofenac. Asian J Pharm 2010;4:235-8. doi: 10.4103/0973-8398.72124
Gulia R, Singh S, Sharma N, Arora S. Hydrotropic solid dispersions: A robust application to undertake solubility challenge. Plant Arch 2020;20:3279-84.
Patel DM, Patel SP, Patel CN. Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion. Int J Pharm Investig 2014;4:174-82. doi: 10.4103/2230-973X.143116, PMID 25426438
Ha ES, Baek IH, Cho W, Hwang SJ, Kim MS. Preparation and evaluation of solid dispersion of atorvastatin calcium with soluplus® by spray drying technique. Chem Pharm Bull (Tokyo) 2014;62:545-51. doi: 10.1248/cpb.c14-00030, PMID 24881660
Suthar RM, Chotai NP, Shah DD. Formulation and evaluation of fast dissolving tablets of ondansetron by solid dispersion in superdisintegrants. Indian J Pharm Educ Res 2013;47:49-55. doi: 10.5530/ijper.47.3.8
Suthar RM, Chotai NP, Patel HK, Patel SR, Shah DD, Jadeja MB. In vitro dissolution enhancement of ondansetron by solid dispersion in superdisintegrants. Dissolution Technol 2013;20:34-8. doi: 10.14227/ DT200413P34
Mohanachandran PS, Sindhumol PG, Kiran TS. Superdisintegrants: An overview. Int J Pharm Sci Rev Res 2011;6:105-9.
Chaulang G, Patel P, Hardikar S, Kelkar M, Bhosale A, Bhise S. Formulation and evaluation of solid dispersions of furosemide in sodium starch glycolate. Trop J Pharm Res 2009;8:43-51. doi: 10.4314/ tjpr.v8i1.14711
Nagarsenker MS, Meshram RN, Ramprakash G. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: Enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats. J Pharm Pharmacol 2000;52:949-56. doi: 10.1211/0022357001774831, PMID 11007065
Sapkal SB, Shinde SA. Solid dispersion of valsartan for solubility improvement using β-cyclodextrin. MOJ BioequivAvailab 2018;5:313-9.
Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603-16. doi: 10.1016/j.addr.2007.05.010, PMID 17619064
Bighley LD, Berge SM, Monkhouse DC. Salt forms of drugs and absorption. Encyclopaedia Pharm Technol 1996;13:453-99.
Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ, et al. An integrated approach to the selection of optimal salt form for a new drug candidate. Int J Pharm 1994;105:209-17. doi: 10.1016/0378- 5173(94)90104-X
Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig 2012;2:12-7. doi: 10.4103/2230-973X.96921, PMID 23071955
Vasconcelos TF, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068-75. doi: 10.1016/j.drudis.2007.09.005, PMID 18061887
Kaur J, Aggarwal G, Singh G, Rana AC. Improvement of drug solubility using solid dispersion. Int J Pharm Pharm Sci 2012;4:47-53.
Alshehri S, Imam SS, Hussain A, Altamimi MA, Alruwaili NK, Alotaibi F, et al. Potential of solid dispersions to enhance solubility, bioavailability and therapeutic efficacy of poorly water-soluble drugs: Newer formulation techniques, current marketed scenario and patents. Drug Deliv 2020;27:1625-43. doi: 10.1080/10717544.2020.1846638, PMID 33207947
Altamimi MA, Elzayat EM, Qamar W, Alshehri SM, Sherif AY, Haq N, et al. Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion. Saudi Pharm J 2019;27:629-36. doi: 10.1016/j. jsps.2019.03.004, PMID 31297016
Alshehri S, Shakeel F, Elzayat E, Almeanazel O, Altamimi M, Shazly G, et al. Rat palatability, pharmacodynamics effect and bioavailability of mefenamic acid formulations utilizing hot-melt extrusion technology. Drug Dev Ind Pharm 2019;45:1610-6. doi: 10.1080/03639045.2019.1645161, PMID 31311329
Soni GC, Chaudhary PD, Sharma PK. Solubility enhancement of poorly water soluble drug aceclofenac. Indian J Pharm Pharmacol 2016;3:139-45. doi: 10.5958/2393-9087.2016.00030.3
Tiwari BK, Gupta V, Jain A, Pandey A. Enhancement of solubility of aceclofenac by using different solubilization technique. Int J Pharm Life Sci 2011;2:620-4.
Semalty A, Semalty M, Rawat BS, Singh D, Rawat MS. Development and evaluation of pharmacosomes of aceclofenac. Indian J Pharm Sci 2010;72:576-81. doi: 10.4103/0250-474X.78523, PMID 21694988
Malik MZ, Ahmad M, Minhas MU, Munir A. Solubility and permeability studies of aceclofenac in different oils. Trop J Pharm Res 2014;13:327-30. doi: 10.4314/tjpr.v13i3.2
Shakeel F, Ramadan W, Shafiq S. Solubility and dissolution improvement of aceclofenac using different nanocarriers. J BioequivAvailab 2009;1:39-43.
Samal HB, Debata J, Kumar NN, Sneha S, Patra PK. Solubility and dissolution improvement of aceclofenacusing β-cyclodextrin. Int J Drug Dev Res 2012;4:326-33.
Choudhary A, Rana AC, Aggarwal G, Kumar V, Zakir F. Development and characterization of anatorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharmacol Sin B 2012;2:421-8. doi: 10.1016/j.apsb.2012.05.002
Moideen MM, Alqahtani A, Venkatesan K, Ahmad F, Krisharaju K, Gayasuddin M, et al. Application of the box-behnken design for the production of soluble curcumin: Skimmed milk powder inclusion complex for improving the treatment of colorectal cancer. Food Sci Nutr 2020;8:6643-59.
Sonar PA, Behera AL, Banerjee SK, Gaikwad DD, Harer SL. Preparation and characterization of simvastatin solid dispersion using skimmed milk. Drug Dev Ind Pharm 2015;41:22-7. doi: 10.3109/03639045.2013.845836, PMID 24160569
Sharma N, Jain N, Sudhakar CK, Jain S. Formulation and evaluation of gastro retentive floating tablets containing cefpodoxime proxetil solid dispersions. Int J Curr Pharm Res 2012;4:82-7.
Paul AD, Vinay J, Rajyalakshmi KG, Prasad PV. Formulation design for poorly water-soluble drug by using solid dispersion of telmisartan for solubility and dissolution rate enhancement. Glob J Pharm Sci 2019;7:1-11
Sapkal S, Narkhede M, Babhulkar M, Mehetre G, Rathi A. Natural polymers: Best carriers for improving bioavailability of poorly water soluble drugs in solid dispersions. Marmara Pharm J 2013;2:65-72.
Nikghalb LA, Singh G, Singh G, Kahkeshan KF. Solid dispersion: Methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci 2012;2:170-5.
Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005;293:145-53. doi: 10.1016/j.ijpharm.2004.12.018, PMID 15778052
Katore GS, Bidkar SJ, Dama GY. Formulation and evaluation of ciprofloxacin solid dispersion controlled release floating capsules for solubility improvement. Indian J Pharm Biol Res 2017;5:7-16.
Rahman Z, Zidan AS, Khan MA. Risperidone solid dispersion for orally disintegrating tablet: Its formulation design and non-destructive methods of evaluation. Int J Pharm 2010;400:49-58. doi: 10.1016/j. ijpharm.2010.08.025, PMID 20801200
Sakure K, Kumari L, Badwaik H. Development and evaluation of solid dispersion based rapid disintegrating tablets of poorly water-soluble anti-diabetic drug. J Drug Deliv Sci Technol 2020;60:2-29. doi: 10.1016/j.jddst.2020.101942
Chae JS, Chae BR, Shin DJ, Goo YT, Lee ES, Yoon HY, et al. Tablet formulation of a polymeric solid dispersion containing amorphous alkalinized telmisartan. AAPS PharmSciTech 2018;19:2990-9. doi: 10.1208/s12249-018-1124-y, PMID 30043191
Das PS, Verma S, Saha P. Fast dissolving tablet using solid dispersion technique: A review. Int J Curr Pharm Res 2017;9:1-4. doi: 10.22159/ ijcpr.2017v9i6.23435
Varma MM, Kumar PS. Formulation and evaluation of gliclazide tablets containing PVP-K30 and hydroxypropyl-β-cyclodextrin solid dispersion. Int J Pharm Sci Nanotechnol 2012;5:1706-19.
Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 2006;7:E55. doi: 10.1208/pt070255, PMID 16796372
Raj AR, Das AC, Sreerekha S, Harindran J. Formulation and evaluation of verapamil solid dispersion tablets for solubility enhancement. J Pharm Sci 2016;7:39-54.
Madhok S, Madhok A. Enhancement of solubility and dissolution of carvedilol by solid dispersion technique using rota-evaporation and lyophilization methods. Int J Drug Res Tech 2015;5:81-102.
Rewar S, Bansal BK, Singh CJ, Sharma AK. Preparation and evaluation of eprosartan mesylate solid dispersions. Elixir Pharm 2015;80:30810-4.
Shah M, Patel D. Design and evaluation of fast dissolving tablet containing tadalafil solid dispersion. Crit Rev 2020;7:579-82.
Sapkal S, Babhulkar M, Rathi A, Mehetre G, Narkhede M. An overview on the mechanisms of solubility and dissolution rate enhancement in solid dispersion. Int J Pharm Tech Res 2013;5:31-9.
Vemula VR, Lagishetty V, Lingala S. Solubility enhancement techniques. Int J Pharm Sci Rev Res 2010;5:41-51.
Kesarwani P, Rastogi S, Bhalla V, Arora V. Solubility enhancement of poorly water-soluble drugs: A review. Int J Pharm Sci Res 2014;5:3123-7.
Das A, Nayak AK, Mohanty B, Panda S. Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers. ISRN Pharm 2011;2011:819765. doi: 10.5402/2011/819765, PMID 22389861
Saharan VA, Kukka V, Kataria M, Gera M, Choudhury PK. Dissolution enhancement of drugs Part II: Effect of carriers. Int J Health Res 2009;2:207-23. doi: 10.4314/ijhr.v2i3.47904
Kanikkannan N. Technologies to improve the solubility, dissolution, and bioavailability of poorly soluble drugs. J Anal Pharm Res 2018;7:44-50.
Manna S, Kollabathula J. Formulation and evaluation of ibuprofen controlled release matrix tablets using its solid dispersion. Int J Appl Pharm 2019;11:71-6. doi: 10.22159/ijap.2019v11i2.30503
McFall H, Sarabu S, Shankar V, Bandari S, Murthy SN, Kolter K, et al. Formulation of aripiprazole loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. Int J Pharm 2019;554:302-11. doi: 10.1016/j.ijpharm.2018.11.005, PMID 30395959
Isobe N, Noguchi K, Nishiyama Y, Kimura S, Wada M, Kuga S. Role of urea in alkaline dissolution of cellulose. Cellulose 2013;20:97-103. doi: 10.1007/s10570-012-9800-7
Gunnarsson M, Hasani M, Bernin D. Influence of urea on methyl β-D-glucopyranoside in alkali at different temperatures. Cellulose 2019;26:9413-22. doi: 10.1007/s10570-019-02730-4
Shah M, Patel D. Development and characterization of tadalafil solid dispersion using skimmed milk for improved the solubility and dissolution release profile. J Pharm Technol 2020;13:6212-7. doi: 10.5958/0974-360X.2020.01083.5
Arali B, Kumar AY, Setty CM. An approach to enhance dissolution rate of rilpivirine by solid dispersion technique. J Pharm Sci Res 2019;11:3145-52.
Shah M, Patel D. Development of an oxcarbazepine solid dispersion using skimmed milk to improve the solubility and dissolution profile. Int J Pharm Sci Drug Res 2019;11:204-9. doi: 10.25004/ IJPSDR.2019.110509
Verma P, Ahuja M, Bhatia M. Novel binary itraconazole-skimmed milk solid dispersion: Preparation and evaluation. Pharm Lett 2016;8:55-64.
Bindhani S, Mohapatra S. Recent approaches of solid dispersion: A new concept towards oral bioavailability. Asian J Pharm Clin Res 2018;11:72-8.
Sumaiyah S, Mentari J, Suryanto S. The effect of crospovidone on the dissolution profile of amlodipine besylate from fast orally dissolving film. Open Access Maced J Med Sci 2019;7:3811-5. doi: 10.3889/ oamjms.2019.510, PMID 32127982
Tamboli JA, Mohite SK. Immediate release solid dispersion tablet of azilsartan: Formulation strategy to enhance oral bioavailability. Int J Appl Pharm 2020;12126-34. doi: 10.22159/ijap.2020v12i4.37695
Palmieri A, Dimmer C, Groben W, Jukka R. Dissolution of suppositories IV: Effect of crospovidone on aspirin release from peg bases. Drug Dev Ind Pharm 1984;10:137-56. doi: 10.3109/03639048409038298
Elmubarak EH, Osman ZA, Rahman MA. Formulation and evaluation of solid dispersion tablets of furosemide using polyvinylpyrrolidone K-30. Int J Curr Pharm Res 2021;13:43-50.
Published
How to Cite
Issue
Section
Copyright (c) 2022 PRASENJIT SARKAR, SUTAPA BISWAS MAJEE
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.